Real-world gait speed estimation, frailty and handgrip strength: a cohort-based study

被引:22
|
作者
Soltani, Abolfazl [1 ]
Abolhassani, Nazanin [2 ,3 ]
Marques-Vidal, Pedro [2 ,3 ]
Aminian, Kamiar [1 ]
Vollenweider, Peter [2 ,3 ]
Paraschiv-Ionescu, Anisoara [1 ]
机构
[1] Ecole Polytech Fed Lausanne EPFL, Lab Movement Anal & Measurement LMAM, Lausanne, Switzerland
[2] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland
[3] Univ Lausanne UNIL, Lausanne, Switzerland
关键词
PHYSICAL-ACTIVITY; WALKING SPEED; GRIP STRENGTH; OLDER-ADULTS; GO TEST; PEOPLE; STEPS; BOUT;
D O I
10.1038/s41598-021-98359-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gait speed is a reliable outcome measure across multiple diagnoses, recognized as the 6th vital sign. The focus of the present study was on assessment of gait speed in long-term real-life settings with the aim to: (1) demonstrate feasibility in large cohort studies, using data recorded with a wrist-worn accelerometer device; (2) investigate whether the walking speed assessed in the real-world is consistent with expected trends, and associated with clinical scores such as frailty/handgrip strength. This cross-sectional study included n = 2809 participants (1508 women, 1301 men, [45-75] years old), monitored with a wrist-worn device for 13 consecutive days. Validated algorithms were used to detect the gait bouts and estimate speed. A set of metrics were derived from the statistical distribution of speed of gait bouts categorized by duration (short, medium, long). The estimated usual gait speed (1-1.6 m/s) appears consistent with normative values and expected trends with age, gender, BMI and physical activity levels. Speed metrics significantly improved detection of frailty: AUC increase from 0.763 (no speed metrics) to 0.798, 0.800 and 0.793 for the 95th percentile of individual's gait speed for bout durations < 30, 30-120 and > 120 s, respectively (all p < 0.001). Similarly, speed metrics also improved the prediction of handgrip strength: AUC increase from 0.669 (no speed metrics) to 0.696, 0.696 and 0.691 for the 95th percentile of individual's gait speed for bout durations < 30, 30-120 and > 120 s, respectively (all p < 0.001). Forward stepwise regression showed that the 95th percentile speed of gait bouts with medium duration (30-120 s) to be the best predictor for both conditions. The study provides evidence that real-world gait speed can be estimated using a wrist-worn wearable system, and can be used as reliable indicator of age-related functional decline.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study
    De Pieri, Marco
    Ferrari, Marco
    Pistis, Giorgio
    Gamma, Franziska
    Marino, Franca
    Von Gunten, Armin
    Conus, Philippe
    Cosentino, Marco
    Eap, Chin-Bin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study
    Rygh, Pontus
    Asklund, Ina
    Samuelsson, Eva
    BMJ OPEN, 2021, 11 (01):
  • [23] IMPACT OF TAFAMIDIS ON SURVIVAL IN A REAL-WORLD COMMUNITY BASED COHORT
    Hussain, Kifah
    Macrinici, Victor
    Wathen, Lucas
    Minga, Iva
    Gaznabi, Safwan
    Kwak, Esther
    Wang, Chi-Hsiung
    Pursnani, Amit
    Sarswat, Nitasha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 517 - 517
  • [24] REAL-WORLD UTILIZATION OF REMDESIVIR IN 2020: A RETROSPECTIVE COHORT STUDY
    Mozaffari, E.
    Chandak, A.
    Liang, S.
    Gayle, J.
    Haubrich, R.
    Thrun, M.
    Hodgkins, P.
    VALUE IN HEALTH, 2021, 24 : S121 - S121
  • [25] Ocrelizumab and hypogammaglobulinemia: a real-world retrospective MS cohort study
    Nobile, S.
    Beauchemin, P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 324 - 324
  • [26] Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study
    Gyldenlove, Mette
    Nissen, Christoffer Valdemar
    Stave, Sascha Dinsen Wreschner
    Thomsen, Simon Francis
    Egeberg, Alexander
    Loft, Nikolai
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (01) : 147 - 150
  • [27] Real-world effectiveness and tolerability of erenumab: A retrospective cohort study
    Kanaan, Saad
    Hettie, Gabrielle
    Loder, Elizabeth
    Burch, Rebecca
    CEPHALALGIA, 2020, 40 (13) : 1511 - 1522
  • [28] Cohort profile: the Northwest China Real-world and Population-based Cohort
    Vanke School of Public Health, Tsinghua University, Beijing, China
    不详
    不详
    不详
    不详
    不详
    不详
    不详
    不详
    不详
    不详
    arXiv,
  • [29] Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study
    Li, Yan Kiu
    Guo, Chuan-Guo
    Cheung, Ka Shing
    Liu, Kevin S. H.
    Leung, Wai K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3051 - 3059
  • [30] Real-world effectiveness of hemodialysis modalities: a retrospective cohort study
    Zhang, Yan
    Winter, Anke
    Ferreras, Belen Alejos
    Carioni, Paola
    Arkossy, Otto
    Anger, Michael
    Kossmann, Robert
    Usvyat, Len A.
    Stuard, Stefano
    Maddux, Franklin W.
    BMC NEPHROLOGY, 2025, 26 (01)